Ology Bioservices is a privately-held emerging biopharmaceutical company with expertise in pre-clinical and clinical development, formulation optimization, and cGMP manufacturing of vaccines, biopharmaceutical products, and medical devices.
RS&H was chosen to design this Advanced Development and Manufacturing Center based upon a depth of expertise in Health and Science facility design and the ability to work as a team member in this public-private partnership. The facility will provide reliable, cost-effective, dedicated capability to the Department of Defense for developing innovative Medical Countermeasure products against chemical, biological, radiological, and nuclear threats. As part of a design-build team and prime architect, RS&H developed the facility master plan and leads the mechanical, electrical, plumbing, fire protection, and civil engineering subconsultants while providing in-house architectural, laboratory programming, landscape architecture, structural engineering consulting services, planning, and design.
The facility provides research and quality control laboratories, BSL-3 bio-containment laboratories and production areas, pilot plant, warehouse, administration offices, and a conference center. Each function is zoned to allow for individual expansion. Production area utilities are fed from an interstitial space.
“RS&H demonstrated a deep understanding of laboratory planning principles, including both cGMP and BSL-3 level clean production areas, and BSL-3 level containment laboratories. Their interior design group provided the appropriate level of finishes and workstation design that maximized utilizable space for our administrative support and training room needs. Their team provided the expertise to lead a combined effort (RS&H, DoD, Ology) to navigate between diverse regulatory requirements and practical production facility efficiencies. ”
– Peter H. Koury, Ph.D., MBA, President & CEO, Ology Bioservices